1. Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways
- Author
-
Takeshi K. Matsui, Eiichiro Mori, Genro Kashino, Atsuhisa Kajihara, Yoshihiko M. Sakaguchi, Tadaaki Kirita, Sotaro Kikuchi, Soichiro S. Ito, Masatoshi Hasegawa, Shinko Kobashigawa, Fumika Kitayoshi, Hitoki Nanaura, Kazuma Sugie, Mari Nakanishi, Masaya Matsubayashi, Shigehiro Tamaki, Akihisa Takahashi, and Yosuke Nakagawa
- Subjects
0301 basic medicine ,DNA End-Joining Repair ,Ultraviolet Rays ,DNA repair ,DNA damage ,Ataxia Telangiectasia Mutated Proteins ,Biochemistry ,03 medical and health sciences ,Cell Line, Tumor ,Neoplasms ,Humans ,Protein Kinase Inhibitors ,Molecular Biology ,030102 biochemistry & molecular biology ,Chemistry ,Kinase ,Autophosphorylation ,DNA replication ,Recombinational DNA Repair ,Cell Biology ,Cell cycle ,Neoplasm Proteins ,Cell biology ,Non-homologous end joining ,030104 developmental biology ,Drug Resistance, Neoplasm ,Fluorouracil ,Homologous recombination - Abstract
The anticancer agent 5-fluorouracil (5-FU) is cytotoxic and often used to treat various cancers. 5-FU is thought to inhibit the enzyme thymidylate synthase, which plays a role in nucleotide synthesis and has been found to induce single- and double-strand DNA breaks. ATR Ser/Thr kinase (ATR) is a principal kinase in the DNA damage response and is activated in response to UV– and chemotherapeutic drug–induced DNA replication stress, but its role in cellular responses to 5-FU is unclear. In this study, we examined the effect of ATR inhibition on 5-FU sensitivity of mammalian cells. Using immunoblotting, we found that 5-FU treatment dose-dependently induced the phosphorylation of ATR at the autophosphorylation site Thr-1989 and thereby activated its kinase. Administration of 5-FU with a specific ATR inhibitor remarkably decreased cell survival, compared with 5-FU treatment combined with other major DNA repair kinase inhibitors. Of note, the ATR inhibition enhanced induction of DNA double-strand breaks and apoptosis in 5-FU–treated cells. Using gene expression analysis, we found that 5-FU induced the activation of the intra-S cell-cycle checkpoint. Cells lacking BRCA2 were sensitive to 5-FU in the presence of ATR inhibitor. Moreover, ATR inhibition enhanced the efficacy of the 5-FU treatment, independently of the nonhomologous end-joining and homologous recombination repair pathways. These findings suggest that ATR could be a potential therapeutic target in 5-FU–based chemotherapy.
- Published
- 2020
- Full Text
- View/download PDF